BeOne Medicines' shares increase by 0.053% after equity awards

BeOne Medicines Ltd. reported an increase in its issued shares, with the closing balance as of September 11, 2025, reaching 1,425,622,549 ordinary shares. This represents an increase from the opening balance of 1,424,804,043 shares as of July 31, 2025.

The change is primarily attributed to the issue of 818,506 new ordinary shares under the Fifth Amended and Restated 2018 Employee Share Purchase Plan, as well as new shares or transfer of treasury shares for other share awards or options granted to participants.

The new shares issued on September 11, 2025, represent 0.053% of the existing number of issued shares before the event. The issue/selling price per share for these new shares was HK$125.06. There were no changes in treasury shares reported for the period, maintaining a balance of 0.

The company clarified that the percentage increase is calculated with reference to the total shares in issue, including those listed on SEHK and the Science and Technology Innovation Board of the Shanghai Stock Exchange. Certain ordinary shares issued to the company's depositary for American Depositary Shares are excluded from the reported balances.